Evidence map›Paper›PMID 31561952›Full record

ArticleMolecular cell2019

Heat Shock Factor 1 Is a Direct Antagonist of AMP-Activated Protein Kinase.

Kuo-Hui Su, Siyuan Dai, Zijian Tang, Meng Xu, Chengkai Dai

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 44 citations in OpenAlex.

  1. Adaptation to heat stress by diversification of the vertebrate heat shock transcription factor family.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2026
    Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Kuo-Hui SuMouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute-Frederick, Frederick, MD 21702, USA.
Siyuan DaiGraduate School of Biomedical Sciences, University of Massachusetts Medical School, Worcester, MA 01655, USA.
Zijian TangMouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute-Frederick, Frederick, MD 21702, USA; Graduate programs, Department of Molecular & Biomedical Sciences, The University of Maine, Orono, ME 04469, USA.
Meng XuMouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute-Frederick, Frederick, MD 21702, USA.
Chengkai DaiMouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute-Frederick, Frederick, MD 21702, USA. Electronic address: chengkai.dai@nih.gov.
Center for Cancer Research · USUniversity of Maine · USUniversity of Massachusetts Chan Medical School · US

Funding

Preservation of Proteomic Stability and Promotion of Protein Lipidation by HSF1ZIABC011767 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI DAI, CHENGKAI · 2017 to 2025
$10.3M
(PQA1) Molecular Mechanism of Metformin in CancerR21CA184704 · NCI · JACKSON LABORATORY · PI DAI, CHENGKAI · 2014 to 2015
$419k
Intramural NIH HHS ZIA BC011767NCI NIH HHS HHSN261200800001ENCI NIH HHS R21 CA184704
6 · The paper itself

Abstract

Through transcriptional control of the evolutionarily conserved heat shock, or proteotoxic stress, response, heat shock factor 1 (HSF1) preserves proteomic stability. Here, we show that HSF1, a physiological substrate for AMP-activated protein kinase (AMPK), constitutively suppresses this central metabolic sensor. By physically evoking conformational switching of AMPK, HSF1 impairs AMP binding to the γ subunits and enhances the PP2A-mediated de-phosphorylation, but it impedes the LKB1-mediated phosphorylation of Thr172, and retards ATP binding to the catalytic α subunits. These immediate and manifold regulations empower HSF1 to both repress AMPK under basal conditions and restrain its activation by diverse stimuli, thereby promoting lipogenesis, cholesterol synthesis, and protein cholesteroylation. In vivo, HSF1 antagonizes AMPK to control body fat mass and drive the lipogenic phenotype and growth of melanomas independently of its intrinsic transcriptional action. Thus, the physical AMPK-HSF1 interaction epitomizes a reciprocal kinase-substrate regulation whereby lipid metabolism and proteomic stability intertwine.

Indexed as

Energy MetabolismAdenosine MonophosphateAdenosine TriphosphateAdiposityAMP-Activated Protein KinasesAnimalsBinding SitesCell ProliferationCholesterolHeat Shock Transcription FactorsHEK293 CellsHeLa CellsHumansLipogenesisMelanomaMice, 129 StrainAdenosine MonophosphateAdenosine TriphosphateAMP-Activated Protein KinasesCholesterolHeat Shock Transcription FactorsHSF1 protein, humanHsf1 protein, mousePRKAA1 protein, humanPrkaa1 protein, mousePRKAA2 protein, humanPrkaa2 protein, ratAMPKcholesteroylationconformational switchHSF1lipogenesisLKB1oncogenesisSHHSREBP1

Identifiers

PMID31561952
PMCPMC8170832
OpenAlexW2975259761

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.